Literature DB >> 10584068

Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking.

B Kramer1, M Rarey, T Lengauer.   

Abstract

We report on a test of FLEXX, a fully automatic docking tool for flexible ligands, on a highly diverse data set of 200 protein-ligand complexes from the Protein Data Bank. In total 46.5% of the complexes of the data set can be reproduced by a FLEXX docking solution at rank 1 with an rms deviation (RMSD) from the observed structure of less than 2 A. This rate rises to 70% if one looks at the entire generated solution set. FLEXX produces reliable results for ligands with up to 15 components which can be docked in 80% of the cases with acceptable accuracy. Ligands with more than 15 components tend to generate wrong solutions more often. The average runtime of FLEXX on this test set is 93 seconds per complex on a SUN Ultra-30 workstation. In addition, we report on "cross-docking" experiments, in which several receptor structures of complexes with identical proteins have been used for docking all cocrystallized ligands of these complexes. In most cases, these experiments show that FLEXX can acceptably dock a ligand into a foreign receptor structure. Finally we report on screening runs of ligands out of a library with 556 entries against ten different proteins. In eight cases FLEXX is able to find the original inhibitor within the top 7% of the total library.

Mesh:

Substances:

Year:  1999        PMID: 10584068     DOI: 10.1002/(sici)1097-0134(19991101)37:2<228::aid-prot8>3.0.co;2-8

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  140 in total

1.  Ligand-receptor docking with the Mining Minima optimizer.

Authors:  L David; R Luo; M K Gilson
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

2.  A virtual high throughput screen for high affinity cytochrome P450cam substrates. Implications for in silico prediction of drug metabolism.

Authors:  G M Keseru
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

3.  Modeling the structural and reactivity properties of hydrazono methyl-4H-chromen-4-one derivatives-wavefunction-dependent properties, molecular docking, and dynamics simulation studies.

Authors:  Y Sheena Mary; Y Shyma Mary; K S Resmi; S Sarala; Rohitash Yadav; Ismail Celik
Journal:  J Mol Model       Date:  2021-05-26       Impact factor: 1.810

4.  Flexible docking under pharmacophore type constraints.

Authors:  Sally A Hindle; Matthias Rarey; Christian Buning; Thomas Lengaue
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

5.  On the evaluation and optimization of protein X-ray structures for pKa calculations.

Authors:  Jens Erik Nielsen; J Andrew McCammon
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

6.  Validation of an empirical RNA-ligand scoring function for fast flexible docking using Ribodock.

Authors:  S David Morley; Mohammad Afshar
Journal:  J Comput Aided Mol Des       Date:  2004-03       Impact factor: 3.686

7.  Molecular modelling studies on the ORL1-receptor and ORL1-agonists.

Authors:  Britta M Bröer; Marion Gurrath; Hans-Dieter Höltje
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

8.  Comparative study of several algorithms for flexible ligand docking.

Authors:  Badry D Bursulaya; Maxim Totrov; Ruben Abagyan; Charles L Brooks
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

9.  Improving inverse docking target identification with Z-score selection.

Authors:  Stephanie S Kim; Melanie L Aprahamian; Steffen Lindert
Journal:  Chem Biol Drug Des       Date:  2019-01-02       Impact factor: 2.817

10.  Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.

Authors:  Zhenghong Peng; David S Maxwell; Duoli Sun; Basvoju A Bhanu Prasad; Ashutosh Pal; Shimei Wang; Julius Balatoni; Pradip Ghosh; Seok T Lim; Andrei Volgin; Aleksander Shavrin; Mian M Alauddin; Juri G Gelovani; William G Bornmann
Journal:  Bioorg Med Chem       Date:  2013-11-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.